Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production

被引:153
作者
Singh, Vivek P. [1 ]
Baker, Kenneth M. [1 ]
Kumar, Rajesh [1 ]
机构
[1] Texas A&M HSC, Coll Med, Cardiovasc Res Inst,Div Mol Cardiol, Scott & White & Cent Texas Vet Hlth Care Syst, Temple, TX 76504 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2008年 / 294卷 / 04期
关键词
angiotensin II; intracrine; hyperglycemia; renin; collagen; transforming growth factor-beta;
D O I
10.1152/ajpheart.91493.2007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The occurrence of a functional intracellular renin-angiotensin system (RAS) has emerged as a new paradigm. Recently, we and others demonstrated intracellular synthesis of ANG II in cardiac myocytes and vascular smooth muscle cells that was dramatically stimulated in high glucose conditions. Cardiac fibroblasts significantly contribute to diabetes-induced diastolic dysfunction. The objective of the present study was to determine the existence of the intracellular RAS in cardiac fibroblasts and its role in extracellular matrix deposition. Neonatal rat ventricular fibroblasts were serum starved and exposed to isoproterenol or high glucose in the absence or presence of candesartan, which was used to prevent receptor-mediated uptake of ANG II. Under these conditions, an increase in ANG II levels in the cell lysate represented intracellular synthesis. Both isoproterenol and high glucose significantly increased intracellular ANG II levels. Confocal microscopy revealed perinuclear and nuclear distribution of intracellular ANG II. Consistent with intracellular synthesis, Western analysis showed increased intracellular levels of renin following stimulation with isoproterenol and high glucose. ANG II synthesis was catalyzed by renin and angiotensin-converting enzyme (ACE), but not chymase, as determined using specific inhibitors. High glucose resulted in increased transforming growth factor-beta and collagen-1 synthesis by cardiac fibroblasts that was partially inhibited by candesartan but completely prevented by renin and ACE inhibitors. In conclusion, cardiac fibroblasts contain a functional intracellular RAS that participates in extracellular matrix formation in high glucose conditions, an observation that may be helpful in developing an appropriate therapeutic strategy in diabetic conditions.
引用
收藏
页码:H1675 / H1684
页数:10
相关论文
共 55 条
[1]  
Agodoa L, 2007, J HYPERTENS, V25, P951
[2]   The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy [J].
Asbun, J ;
Villarreal, FJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) :693-700
[3]   Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E [J].
Asbun, J ;
Manso, AM ;
Villarreal, FJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (01) :H227-H234
[4]   Intracellular angiotensin II induces cell proliferation independent of AT1 receptor [J].
Baker, Kenneth M. ;
Kumar, Rajesh .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (05) :C995-C1001
[5]   Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy [J].
Baker, KM ;
Chernin, MI ;
Schreiber, T ;
Sanghi, S ;
Haiderzaidi, S ;
Booz, GW ;
Dostal, DE ;
Kumar, R .
REGULATORY PEPTIDES, 2004, 120 (1-3) :5-13
[6]   Dynamic interactions between myocytes, fibroblasts, and extracellular matrix [J].
Banerjee, Indroneal ;
Yekkala, Krishna ;
Borg, Thomas K. ;
Baudino, Troy A. .
INTERACTIVE AND INTEGRATIVE CARDIOLOGY, 2006, 1080 :76-84
[7]   Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure [J].
Barlucchi, L ;
Leri, A ;
Dostal, DE ;
Fiordaliso, F ;
Tada, H ;
Hintze, TH ;
Kajstura, J ;
Nadal-Ginard, B ;
Anversa, P .
CIRCULATION RESEARCH, 2001, 88 (03) :298-304
[8]  
Booz GW, 1999, AM J CARDIOL, V83, p44H
[9]   The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure [J].
Brown, RD ;
Ambler, SK ;
Mitchell, MD ;
Long, CS .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :657-687
[10]   Structural and functional characterisation of cardiac fibroblasts [J].
Camelliti, P ;
Borg, TK ;
Kohl, P .
CARDIOVASCULAR RESEARCH, 2005, 65 (01) :40-51